IO Biotech, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: IO Biotech, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
IO Biotech, Inc. Assets for the quarter ending September 30, 2024 was $89.9M, a 47.9% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$89.9M	-$82.6M	-47.9%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$111M	-$6.09M	-5.18%	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$128M	-$8.69M	-6.35%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$151M	-$1.09M	-0.72%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$173M	+$10.4M	+6.41%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$118M	-$65.1M	-35.6%	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$137M	-$65.3M	-32.3%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$152M	-$70.5M	-31.7%	Dec 31, 2022	10-K	2024-03-05
Q3 2022	$162M	+$110M	+212%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$183M			Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$202M			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$222M	+$217M	+3832%	Dec 31, 2021	10-K	2023-03-14
Q3 2021	$52M			Sep 30, 2021	10-Q	2021-12-17
Q4 2020	$5.65M			Dec 31, 2020	10-K	2022-03-31

* An asterisk sign (*) next to the value indicates that the value is likely invalid.